Elanco Animal Health (ELAN) Cash from Investing Activities (2017 - 2026)

Elanco Animal Health has disclosed Cash from Investing Activities across 10 years of filings, most recently posting -$60.0 million for Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$60.0 million, down 3.45% year-over-year; the trailing twelve-month figure through Mar 2026 was -$281.0 million (down 126.43% YoY), and the FY2025 annual result was -$279.0 million, down 124.09% from the prior year.
• Cash from Investing Activities came in at -$60.0 million for Q1 2026 at Elanco Animal Health, up from -$64.0 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $1.2 billion in Q3 2024 to a low of -$101.0 million in Q3 2025.
• The 5-year median for Cash from Investing Activities is -$43.0 million (2023), against an average of $27.7 million.
• Across the five-year window, Cash from Investing Activities slumped 390.0% in 2022 and soared 3555.56% in 2024, its largest moves.
• Elanco Animal Health's Cash from Investing Activities stood at -$76.0 million in 2022, then jumped by 53.95% to -$35.0 million in 2023, then slumped by 157.14% to -$90.0 million in 2024, then rose by 28.89% to -$64.0 million in 2025, then rose by 6.25% to -$60.0 million in 2026.
• The last three Cash from Investing Activities figures came in at -$60.0 million (Q1 2026), -$64.0 million (Q4 2025), and -$101.0 million (Q3 2025), per Business Quant data.